查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
放射肿瘤学市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和地理位置
市场调查报告书
商品编码
1558381

放射肿瘤学市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和地理位置

Radiation Oncology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography
出版日期: | 出版商: The Insight Partners | 英文 170 Pages | 订单完成后即时交付

价格

根据我们关于「2031 年放射肿瘤学市场预测 - 全球分析 - 按类型、应用和地理位置」的新研究，该市场预计将从 2023 年的 8,924.44 百万美元增长到 2023 年达到 23,620.56 百万美元。 ；预计 2023-2031 年复合年增长率为 13.0%。放射肿瘤学市场的成长归因于癌症盛行率的增加以及支持放射肿瘤学发展的措施的激增。放射肿瘤学市场参与者的策略性倡议可能会为市场成长提供机会。放射肿瘤学市场报告强调了推动市场的关键因素，并展示了知名参与者的发展。

放射治疗或放射治疗是一种常见的癌症治疗方法，它使用放射（通常是高能量 X 光）来杀死癌细胞。放射治疗可以单独使用，也可以与其他治疗一起使用，例如手术或化疗。放射肿瘤科医师是专门从事放射治疗的医疗保健提供者。

2023年，北美在全球放射肿瘤学市场中占据主要份额。在美国，所有癌症患者都可以广泛使用放射治疗，并且对放射肿瘤科医师的需求不断增加。由于医疗保健基础设施的发达，这些专业人员的数量也不断增加。儘管如此，美国临床肿瘤学会估计全球约三分之二的癌症患者接受放射治疗作为治疗的一部分。到 2022 年，预计美国每年将有超过 100 万名癌症患者接受放射治疗。政府和医疗机构正在采取多项措施来鼓励采用放射治疗。 2020 年 6 月，美国放射肿瘤学会 (ASTRO) 推出了非转移性子宫颈癌放射治疗的新临床指南。新指南的重点是精确实施放射治疗的步骤和流程。加拿大放射肿瘤学协会 (CARO) 制定了有关放射肿瘤学的具体指南。 《日本临床肿瘤学杂誌》发表的一项研究报告称，安大略省每年有近 35,000 名患者接受放射治疗，约占该省癌症患者的 39%。加拿大以人口为基础的单一付款人癌症系统不断变化，以提高获取机会、诊断品质、治疗结果和支持。它也很好地定位了放射治疗，确保人们有足够的机会获得这种治疗。儘管如此，获得治疗的情况需要密切监测。随着人口老化和技术进步，加拿大计划继续创新、开展研究并改变放射肿瘤学的实践。癌症发生率上升、政府措施和技术进步是推动墨西哥放射肿瘤学市场成长的几个因素。该国特别记录了肺癌、前列腺癌和乳腺癌的高发生率，导致对有效治疗的放射治疗的需求增加。墨西哥政府致力于吸引大量外国投资和国际参与者。例如，2018 年，Elekta 收到了墨西哥政府提供放射治疗系统的招标。据估计，此类合作将在预测期内推动墨西哥放射肿瘤学市场的发展。

放射肿瘤学的策略性措施为未来提供市场机会

放射肿瘤学在癌症治疗上具有巨大的潜力。此外，市场参与者在产品开发、创新、产品发布、产品批准、合併、收购和合作伙伴关係等方面不断发展放射治疗预计将有助于市场成长。市场上最近采取的一些策略性倡议是

2024 年 5 月，Elekta 推出了最新的直线加速器 (linac) Evo，这是一款具有新型高清 AI 增强成像的 CT-Linac，能够提供离线和线上自适应放射治疗以及改进的标准影像引导放射治疗。

2024 年 5 月，The Icon Group 与 Cyber​​knife Australia Pty Ltd 合作建立多达 6 家新的放射肿瘤诊所（拟成立合资企业），将使用「Cyber​​knife」系统提供放射肿瘤治疗。

2024 年5 月，GE HealthCare 推出了Revolution RT，这是一种新型放射治疗电脑断层扫描(CT) 解决方案，具有创新的硬体和软体解决方案，有助于提高成像准确性，同时简化模拟工作流程，为临床医生和患者提供更个人化和无缝的肿瘤护理路径体验。

2024 年4 月，Accuray Incorporated 在ESTRO 2024 上展示了旨在改善癌症治疗体验的硬体和软体的进步。所需的技术。

2023年10月，CIVCO放射治疗与Qfix推出新品牌CQ Medical。该公司专注于改善癌症护理和患者治疗结果，并与临床医生和技术合作伙伴在该领域进行深入合作。

2023 年 9 月，MVision AI 推出了第一个全面的基于指南的分割 (GBS) 解决方案，用于有效的放射治疗轮廓绘製。 Guide 有助于临床团队准确评估人工智慧生成的结构，从而使他们能够提高轮廓绘製技能。验证可以对轮廓进行视觉和体积比较，方便诊所观察相似点和差异。 Guide verify 和 Contour+ 的组合实施涵盖了放射治疗轮廓的所有临床需求。

因此，放射肿瘤学市场的市场参与者的策略性倡议不断涌现，预计将放大市场成长并为放射肿瘤学市场创造充足的机会。

放射肿瘤学市场：竞争格局与主要发展

Varian Medical Systems Inc、Elekta AB、Accuracy Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson & Co、Perspective Therapeutics Inc、Nordion、Mevion Medical Systems、NTP Radioisotopes 和 Mallinckrodt Plc。是放射肿瘤市场的主要公司之一。

美国食品药物管理局、疾病管制与预防中心 (CDC) 和美国放射肿瘤学会是准备放射肿瘤学市场报告时提到的主要和次要来源之一。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：放射肿瘤学市场格局

  • 概述
  • PEST分析

第 5 章：放射肿瘤学市场 - 主要市场动态

  • 放射肿瘤学市场 - 主要市场动态
  • 市场驱动因素：
    • 癌症盛行率增加
    • 支持放射肿瘤学发展的倡议
  • 市场限制
    • 放射治疗设备成本高
  • 市场机会
    • 放射肿瘤学的策略性倡议
  • 未来趋势
    • 放射肿瘤学的技术进步
  • 驱动因素和限制的影响：

第 6 章：放射肿瘤学市场 - 全球市场分析

  • 放射肿瘤学市场收入，2021-2031

第 7 章：放射肿瘤学市场分析 - 按类型

  • 外束放射治疗
  • 内束放射治疗

第 8 章：放射肿瘤学市场分析 - 按应用

  • 乳癌
  • 摄护腺癌
  • 肺癌
  • 头颈癌
  • 子宫颈癌
  • 其他的

第 9 章：放射肿瘤学市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 10 章：放射肿瘤学市场 - 产业格局

  • 概述
  • 放射肿瘤学市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Perspective Therapeutics Inc
  • Nordion
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Provision Healthcare
  • Panacea Medical Technologies Pvt. Ltd
  • Curium

第 12 章：附录

Product Code: TIPRE00004195

According to our new research study on "Radiation Oncology Market Forecast to 2031 -Global Analysis - by Type, Application, and Geography," the market is anticipated to grow from US$ 8,924.44 million in 2023 and is projected to reach US$ 23,620.56 million by 2031; it is expected to register a CAGR of 13.0% during 2023-2031. The radiation oncology market growth is attributed to the increasing prevalence of cancer and surging initiatives to support developments in radiation oncology. Strategic initiatives by radiation oncology market players are likely to offer opportunities for market growth. The radiation oncology market report emphasizes the key factors driving the market and showcases the developments of prominent players.

Radiation therapy or radiotherapy is a common cancer treatment that uses radiation (usually high-powered X-rays) to kill cancer cells. Radiation therapy may be used independently or alongside other treatments, like surgery or chemotherapy. Radiation oncologists are healthcare providers who specialize in radiation therapy.

North America accounted for a major share of the global radiation oncology market in 2023. The North America radiation oncology market is segmented into the US, Canada, and Mexico. Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2022, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy. The Canadian Association of Radiation Oncology (CARO) has established specific guidelines about radiation oncology. A study published in the Japanese Journal of Clinical Oncology reports that nearly 35,000 patients in Ontario receive radiation therapy annually, accounting for ~39% of cancer patients in the province. Canada's population-based, single-payer cancer system constantly changes to enhance access, diagnosis quality, treatment outcomes, and support. It has also positioned radiotherapy well, ensuring that people have sufficient access to this treatment. Nonetheless, access to the treatment needs close monitoring. Canada plans to continue to innovate, conduct research, and change the practice of radiation oncology as its population ages and technology advances. Rising cancer incidence, government initiatives, and technology improvements are a few factors driving growth of the radiation oncology market in Mexico. The country specifically records high incidences of lung, prostate, and breast cancer, resulting in an elevated demand for radiation therapy for effective treatment. The government of Mexico focuses on attracting significant foreign investments and international players. For instance, in 2018, Elekta received a tender from the government of Mexico to deliver radiation therapy systems. Such collaborations are estimated to boost the Mexico radiation oncology market during the forecast period.

Strategic Initiatives in Radiation Oncology to Provide Market Opportunities in Future

Radiation oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.

In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.

In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.

In October 2023, CIVCO Radiotherapy and Qfix launched a new brand CQ Medical. The company focuses on the improvement of cancer care and patient outcome along with deep engagement in the field with clinicians and technology partners.

In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Radiation Oncology Market: Competitive Landscape and Key Developments

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc. are among the key companies operating in the radiation oncology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Radiation Oncology are among the primary and secondary sources referred to while preparing the radiation oncology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Radiation Oncology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Radiation Oncology Market - Key Market Dynamics

  • 5.1 Radiation Oncology Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Cancer
    • 5.2.2 Initiatives to Support Developments in Radiation Oncology
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Radiotherapy Equipment
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Radiation Oncology
  • 5.5 Future Trends
    • 5.5.1 Technological Advancement in Radiation Oncology
  • 5.6 Impact of Drivers and Restraints:

6. Radiation Oncology Market - Global Market Analysis

  • 6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. Radiation Oncology Market Analysis - by Types

  • 7.1 External Beam Radiation Therapy
    • 7.1.1 Overview
    • 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Internal Beam Radiation Therapy
    • 7.2.1 Overview
    • 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Radiation Oncology Market Analysis - by Application

  • 8.1 Breast Cancer
    • 8.1.1 Overview
    • 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Prostate Cancer
    • 8.2.1 Overview
    • 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lung Cancer
    • 8.3.1 Overview
    • 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Head and Neck Cancer
    • 8.4.1 Overview
    • 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Cervical Cancer
    • 8.5.1 Overview
    • 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. Radiation Oncology Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Radiation Oncology Market Overview
    • 9.1.2 North America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.2.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.1.2.2 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.1.2.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.1.2.4 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.1.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
  • 9.2 Europe
    • 9.2.1 Europe Radiation Oncology Market Overview
    • 9.2.2 Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.2.2.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.2.2.2 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.2.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.2.2.4 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Radiation Oncology Market Overview
    • 9.3.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.3.2.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.3.2.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.3.2.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.3.2.4 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.3.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
        • 9.3.3.5.5 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa Radiation Oncology Market Overview
    • 9.4.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.4.2.1 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.4.2.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.4.2.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.4.2.4 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.4.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
  • 9.5 South and Central America
    • 9.5.1 South and Central America Radiation Oncology Market Overview
    • 9.5.2 South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.5.2.1 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.5.2.2 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.5.2.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.5.2.4 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.5.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.2 Argentina: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.3 Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Radiation Oncology Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Varian Medical Systems Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview (Siemens Healthineers AG)
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Accuray Incorporated
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 IBA Worldwide (Ion Beam Applications SA)
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Perspective Therapeutics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Nordion
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Mevion Medical Systems
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NTP RADIOISOTOPES
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Mallinckrodt Plc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Provision Healthcare
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Panacea Medical Technologies Pvt. Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 Curium
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Radiation Oncology Market Segmentation
  • Table 2. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 27. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 28. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 29. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 30. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 31. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 32. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 33. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 35. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 36. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 37. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 38. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 39. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 40. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 41. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 42. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 43. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 44. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 45. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 46. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 47. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 48. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 49. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 51. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 52. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 53. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 54. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 55. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 56. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 57. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 58. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 59. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 60. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 61. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 63. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 64. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 65. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 66. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 67. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 68. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 69. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 70. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 71. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 72. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 73. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 74. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 75. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 76. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 77. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 79. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 80. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 81. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 82. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 83. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 84. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 85. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 86. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 87. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 88. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 89. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 90. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 91. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 92. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 93. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 94. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 95. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 96. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 97. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 98. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 99. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 100. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 101. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 102. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 103. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 104. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 105. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 106. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 107. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 108. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 109. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 110. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 111. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 112. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Radiation Oncology Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 17. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Middle East and Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South and Central America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 45. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Growth Strategies in Radiation Oncology Market